Literature DB >> 31994436

Neuronal microRNAs modulate TREK two-pore domain K+ channel expression and current density.

Maria Paschou1,2, Larisa Maier3, Panagiota Papazafiri2, Tudor Selescu3, Skarlatos G Dedos2, Alexandru Babes3, Epaminondas Doxakis1.   

Abstract

The TREK family of leak potassium channels has been found to play critical roles in nociception, sensitivity to general anaesthetics, neuroprotection, and memory. The three members of the family, TREK1, TREK2 and TRAAK establish the resting potential and modify the duration, frequency and amplitude of action potentials. Despite their apparent importance, the repertoire of regulatory interactions utilized by cells to control their expression is poorly understood. Herein, the contribution of miRNAs in the regulation of their post-transcriptional gene expression has been examined. Using different assays, miR-124 and to a lesser extent miR-128 and miR-183 were found to reduce TREK1 and TREK2 levels through specific binding to their 3'UTRs. In contrast, miR-9 which was predicted to bind to TRAAK 3'UTR, did not alter its expression. Expression of miR-124, miR-128 and miR-183 was found to mirror that of Trek1 and Trek2 mRNAs during brain development. Moreover, application of proinflammatory mediators in dorsal root ganglion (DRG) neurons revealed an inverse correlation between miR-124 and Trek1 and Trek2 mRNA expression. Voltage clamp recordings of TREK2-mediated currents showed that miR-124 reduced the sensitivity of TREK2-expressing cells to non-aversive warmth stimulation. Overall, these findings reveal a significant regulatory mechanism by which TREK1 and TREK2 expression and hence activity are controlled in neurons and uncover new druggable targets for analgesia and neuroprotection.Abbreviations: microRNA: miRNA; UTR: untranslated region; K2p channels: two-pore domain K+channels; DRG: dorsal root ganglion; CNS: central nervous system; FBS: fetal bovine serum; TuD: Tough Decoy; TREK: tandem P-domain weak inward rectifying K+ (TWIK)-related K+ channel 1; TRAAK: TWIK-related arachidonic acid K+.

Entities:  

Keywords:  TRAAK; TREK1; TREK2; miR-124; miR-128; miR-183

Mesh:

Substances:

Year:  2020        PMID: 31994436      PMCID: PMC7237132          DOI: 10.1080/15476286.2020.1722450

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  55 in total

1.  miR-124-3p attenuates neuropathic pain induced by chronic sciatic nerve injury in rats via targeting EZH2.

Authors:  Yang Zhang; Hai-Lin Liu; Li-Jun An; Lin Li; Meng Wei; Dong-Jian Ge; Zhen Su
Journal:  J Cell Biochem       Date:  2018-11-02       Impact factor: 4.429

2.  Thermosensitivity of the two-pore domain K+ channels TREK-2 and TRAAK.

Authors:  Dawon Kang; Changyong Choe; Donghee Kim
Journal:  J Physiol       Date:  2005-01-27       Impact factor: 5.182

Review 3.  MicroRNA function in animal development.

Authors:  Erno Wienholds; Ronald H A Plasterk
Journal:  FEBS Lett       Date:  2005-08-10       Impact factor: 4.124

4.  Distribution of miRNA expression across human tissues.

Authors:  Nicole Ludwig; Petra Leidinger; Kurt Becker; Christina Backes; Tobias Fehlmann; Christian Pallasch; Steffi Rheinheimer; Benjamin Meder; Cord Stähler; Eckart Meese; Andreas Keller
Journal:  Nucleic Acids Res       Date:  2016-02-25       Impact factor: 16.971

5.  Role of the TREK2 potassium channel in cold and warm thermosensation and in pain perception.

Authors:  Vanessa Pereira; Jérôme Busserolles; Marine Christin; Maïly Devilliers; Laura Poupon; Wassim Legha; Abdelkrim Alloui; Youssef Aissouni; Emmanuel Bourinet; Florian Lesage; Alain Eschalier; Michel Lazdunski; Jacques Noël
Journal:  Pain       Date:  2014-09-18       Impact factor: 6.961

6.  Maternally inherited Birk Barel mental retardation dysmorphism syndrome caused by a mutation in the genomically imprinted potassium channel KCNK9.

Authors:  Ortal Barel; Stavit A Shalev; Rivka Ofir; Asi Cohen; Joel Zlotogora; Zamir Shorer; Galia Mazor; Gal Finer; Shareef Khateeb; Noam Zilberberg; Ohad S Birk
Journal:  Am J Hum Genet       Date:  2008-08       Impact factor: 11.025

7.  A mammalian microRNA expression atlas based on small RNA library sequencing.

Authors:  Pablo Landgraf; Mirabela Rusu; Robert Sheridan; Alain Sewer; Nicola Iovino; Alexei Aravin; Sébastien Pfeffer; Amanda Rice; Alice O Kamphorst; Markus Landthaler; Carolina Lin; Nicholas D Socci; Leandro Hermida; Valerio Fulci; Sabina Chiaretti; Robin Foà; Julia Schliwka; Uta Fuchs; Astrid Novosel; Roman-Ulrich Müller; Bernhard Schermer; Ute Bissels; Jason Inman; Quang Phan; Minchen Chien; David B Weir; Ruchi Choksi; Gabriella De Vita; Daniela Frezzetti; Hans-Ingo Trompeter; Veit Hornung; Grace Teng; Gunther Hartmann; Miklos Palkovits; Roberto Di Lauro; Peter Wernet; Giuseppe Macino; Charles E Rogler; James W Nagle; Jingyue Ju; F Nina Papavasiliou; Thomas Benzing; Peter Lichter; Wayne Tam; Michael J Brownstein; Andreas Bosio; Arndt Borkhardt; James J Russo; Chris Sander; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

8.  Neurofibromin 1 is a miRNA target in neurons.

Authors:  Maria Paschou; Epaminondas Doxakis
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

9.  Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs.

Authors:  David M Garcia; Daehyun Baek; Chanseok Shin; George W Bell; Andrew Grimson; David P Bartel
Journal:  Nat Struct Mol Biol       Date:  2011-09-11       Impact factor: 15.369

10.  Optimal choice of functional and off-target effect-reduced siRNAs for RNAi therapeutics.

Authors:  Kumiko Ui-Tei
Journal:  Front Genet       Date:  2013-06-11       Impact factor: 4.599

View more
  3 in total

1.  Neuronal microRNAs safeguard ER Ca2+ homeostasis and attenuate the unfolded protein response upon stress.

Authors:  Maria Paschou; Panagiota Papazafiri; Chrysanthi Charalampous; Michael Zachariadis; Skarlatos G Dedos; Epaminondas Doxakis
Journal:  Cell Mol Life Sci       Date:  2022-06-21       Impact factor: 9.261

2.  Differentially Expressed Circular RNAs in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease.

Authors:  Stylianos Ravanidis; Anastasia Bougea; Dimitra Karampatsi; Nikolaos Papagiannakis; Matina Maniati; Leonidas Stefanis; Epaminondas Doxakis
Journal:  Mov Disord       Date:  2021-01-12       Impact factor: 10.338

Review 3.  Insights into the multifaceted role of circular RNAs: implications for Parkinson's disease pathogenesis and diagnosis.

Authors:  Epaminondas Doxakis
Journal:  NPJ Parkinsons Dis       Date:  2022-01-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.